Atectura Breezhaler 160 mcg

ATECTURA BREEZHALER 160 MCG is an inhalation capsule containing mometasone furoate, used for managing respiratory conditions. This medication is designed for easy administration via a Breezhaler device, offering a convenient treatment option for those requiring inhaled corticosteroids.

ATECTURA BREEZHALER 160 MCG is primarily used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). It works by reducing inflammation in the airways, which can help improve breathing and reduce symptoms such as wheezing and shortness of breath. This medication is often prescribed to individuals who require long-term management of their respiratory conditions.

Common effects of ATECTURA BREEZHALER 160 MCG may include throat irritation, hoarseness, and a dry mouth. Some users might experience headaches or a fungal infection in the mouth or throat, known as oral candidiasis. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare professional.

ATECTURA BREEZHALER 160 MCG should be used with caution in individuals with a history of respiratory infections or tuberculosis. It is important to follow the prescribed dosage and administration instructions to minimize the risk of side effects. Regular monitoring by a healthcare professional is recommended, especially for long-term use.

ATECTURA BREEZHALER 160 MCG may interact with other medications, including certain antifungal and antiviral drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol should be avoided as it may exacerbate some side effects.